Physicochemical Properties
| Molecular Formula | C27H42N2O |
| Molecular Weight | 410.64 |
| Appearance | Solid powder |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | CB2R |
| ln Vitro | When CB2R antagonist 3 (compound 10a) (1 and 10 µM; 24 h) was combined with the activator CB65, it significantly reduced the expression of pro-inflammatory cytokines TNF-α, IFN-γ, IL-1β, and IL-6, and increased the expression of anti-inflammatory cytokine IL-10 in the presence of lipopolysaccharide [1]. |
| References |
[1]. N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R). Eur J Med Chem. 2023 Feb 15;248:115109. |
Solubility Data
| Solubility (In Vitro) | DMSO : 100 mg/mL (243.52 mM; with sonication (<60°C)) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (6.09 mM) in 10% DMSO 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution; sonication aided. For example, if 1 mL of working solution, add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL corn oil and mix well.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4352 mL | 12.1761 mL | 24.3522 mL | |
| 5 mM | 0.4870 mL | 2.4352 mL | 4.8704 mL | |
| 10 mM | 0.2435 mL | 1.2176 mL | 2.4352 mL |